Myocardial viability in patients with Q wave myocardial infarction and no residual ischemia

G Montalescot1, M Faraggi, G Drobinski

  • 1Service de Cardiologie, Centre Hospitalier Universitaire Pitié-Salpétrière, Paris, France.

Circulation
|July 1, 1992
PubMed

Insights

Percutaneous transluminal coronary angioplasty (PTCA) improved coronary blood flow and myocardial viability in patients with Q wave myocardial infarction. This suggests that residual blood flow in the infarct artery supports myocardial viability for weeks, benefiting from revascularization.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Nuclear Cardiology

Background:

  • Coronary revascularization improves outcomes in post-myocardial infarction patients with persistent angina.
  • The benefit of revascularization in Q wave myocardial infarction without residual ischemia may depend on myocardial viability.

Purpose of the Study:

  • To assess myocardial viability in asymptomatic patients after Q wave myocardial infarction.
  • To compare percutaneous transluminal coronary angioplasty (PTCA) with conservative treatment in patients with no residual ischemia.

Main Methods:

  • 15 asymptomatic patients with Q wave myocardial infarction and single-vessel disease were randomized to PTCA or conservative treatment.
  • Coronary blood flow, 201Tl uptake, and left ventricular wall motion were assessed.
  • Follow-up was conducted after 2 months.

Main Results:

  • PTCA significantly increased coronary blood flow and 201Tl uptake in the infarct area compared to conservative treatment.
  • Regional wall motion improved significantly more after PTCA.
  • Improvements in 201Tl uptake and wall motion correlated significantly.

Conclusions:

  • Successful PTCA of the infarct artery improves coronary flow, 201Tl uptake, and regional wall motion in selected myocardial infarction patients.
  • Myocardial viability can persist for weeks if residual blood flow is maintained.
  • Imaging techniques to assess viability are crucial for identifying patients who will benefit from revascularization.
Abstract

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VI: Nursing Management01:29

Cardiomyopathy VI: Nursing Management

Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...